Trial Profile
A Double Blinded Randomized Placebo Controlled Study Evaluating the Use of Intraoperative Dexmedetomidine in Reducing Postoperative Pain and Narcotic Requirement in Patients With Moderate to Severe OSA.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I/II
Latest Information Update: 10 Aug 2018
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 10 Aug 2018 New trial record